MarketPulse
T

$TLRY

14 articles found
6 positive
7 negative
1 neutral
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Tilray's Revenue Gains Mask Deeper Problems: Why Skeptics Remain Unconvinced

Tilray posts record $217.5M quarterly revenue and narrows losses, but persistent negative cash flow and competitive headwinds keep investors wary.
TLRYrevenue growthcannabis stocks
BenzingaBenzinga··Akanksha Bakshi

Tilray Seals BrewDog Australia Deal, Eyes Asia-Pacific Gateway Despite Stock Decline

Tilray completes BrewDog Australia acquisition with brewery and bars; stock falls 3.68% despite Asia-Pacific expansion strategy.
TLRYacquisitionAsia-Pacific
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Altria's Cash Machine Outpaces Cannabis Volatility as Tilray Struggles

Altria's proven profitability and 6.1% dividend outshine Tilray's persistent losses and shareholder dilution in cannabis sector comparison.
TLRYMOshareholder dilutiondividend yield
BenzingaBenzinga··Stan Vick

Canadian Securities Settlements Reveal Hidden Costs Beyond Legal Payouts

Canadian securities settlements at major companies reveal stock declines, leadership changes, and restructuring far exceed announced legal payouts, exposing systematic disclosure vulnerabilities.
TLRYLSPDstock performanceinvestor confidence
BenzingaBenzinga··Vandana Singh

Tilray Acquires BrewDog Assets for £33M, Eyes $200M Revenue Boost

Tilray acquires BrewDog assets for £33M in bid to boost annual beverage revenue to $500M, though stock falls 4.32% on announcement.
TLRYstock declineacquisition
BenzingaBenzinga··Vandana Singh

Tilray's $200M Revenue Bet: BrewDog Acquisition Faces Skeptical Market

Tilray completes £33M BrewDog acquisition targeting $200M annual revenue boost, but stock falls 4.32% as investors question valuation and integration strategy.
TLRYstock declineacquisition
BenzingaBenzinga··Globe Newswire

Tilray Brands Acquires BrewDog for £33M, Building $500M Global Craft Beer Empire

Tilray acquires BrewDog for £33M, creating ~$500M platform with projected $200M revenue and $6-8M EBITDA by 2027.
TLRYacquisitionrevenue growth
The Motley FoolThe Motley Fool··James Halley

Abbott Laboratories Positions as Dividend Growth Play Amid Diagnostic Headwinds

Abbott maintains 54-year dividend streak with 10% EPS growth projected for 2026, despite near-term diagnostic headwinds and manufacturing challenges offsetting strategic acquisitions and FDA approvals.
ABTEXASTLRYacquisitionhealthcare
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Tilray Faces Profitability Headwinds Despite Diversification Push

Tilray struggles with profitability despite diversification into hemp and beverages. Acquisition-driven growth caused shareholder dilution and asset write-downs, raising questions about long-term viability.
TLRYprofitability concernsacquisition strategy
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Tilray and Canopy Growth Navigate Evolving Cannabis Market Landscape

Tilray and Canopy Growth strengthen positions amid shifting U.S. cannabis regulations. Both improve financials, with Tilray offering broader geographic diversification versus Canopy's focused approach.
CGCTLRYCanopy Growthcannabis stocks
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Cannabis Market Set to Reach $3.32B by 2030 as Premium Innovation Accelerates

Cannabis market projected to grow from $2.24B in 2025 to $3.32B by 2030, driven by legalization, premium products, and innovation in consumption methods.
CGCACBTLRYCRONSNDLmarket growthproduct innovation
BenzingaBenzinga··Prnewswire

Alternative Delivery Systems Propel Functional Foods Toward $438B Valuation

Global functional foods market reaching $438B by 2026 as companies innovate delivery formats like oral pouches and alternative caffeine platforms to meet consumer demand for convenience.
TLRYKHCCRONUSNAcannabisproduct innovation
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Tilray Expands UK Pharma Distribution Through Smartway Partnership

Tilray Pharma partners with Smartway Pharmaceuticals to expand UK drug distribution, combining their networks to strengthen presence in Britain's £1 billion pharma market.
TLRYsupply chainstrategic partnership
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Tilray Expands UK Pharmaceutical Distribution Through CC Pharma Partnership

Tilray expands UK pharmaceutical distribution via CC Pharma's partnership with Smartway Pharmaceuticals, combining distribution networks and manufacturing expertise to serve the £1 billion market.
TLRYsupply chainstrategic partnership